DPhil Interdisciplinary Bioscience (The University of Oxford)
The DNA damage response
Carried out a 6-month industrial placement at AstraZeneca in Cambridge. During this time I developed and optimised a cell-based luminescence assay to monitor the induced degradation of important cancer related protein targets by novel drug molecules called Proteolysis Targeting Chimeras (PROTACs).
Completed a 5-month research project in which I quantified the differential expression of genes associated with antibiotic resistance in the important opportunistic pathogen Bacteroides fragilis, under conditions corresponding to its transition from a commensal to a pathogenic organism.